Pfizer Inc (PFE · NYSE)
PFE · MARKET VIEW
Market view · as of Jun 15, 2026
Revenue (TTM)
$63.32B
+5.4% YoY
Gross margin
74.8%
EPS (latest q)
$0.47
vs $0.52 est · miss
52-wk position
68.5%
-6.7% vs 52w high · +1.8% 1mo
Price (last ~year)
Pfizer (PFE) recently established a strategic partnership with Sinopharm to promote "Diflucan" as the stock trades near $26.21 with a $149.38 billion market capitalization. While trailing twelve-month revenue grew 5.4% to $63.32 billion, annual earnings declined 10.1%. For the quarter ending March 31, 2026, the company reported $14.45 billion in revenue and $2.69 billion in net income, supported by an operating margin of 31.6%.
Valuation
- Market cap
- $149.38B
- P/E
- 20.01
- PEG
- 13.77
- P/B
- 1.658
- P/S
- 2.359
- EV/EBITDA
- 11.65
- Beta
- 0.295
- Analyst target
- $29.19
Quality & returns
- Gross margin
- 74.8%
- Operating margin
- 31.6%
- Profit margin
- 11.8%
- ROE
- 8.3%
- ROA
- 5.7%
Price movement
- Last
- $26.21
- 1-month
- +1.8%
- 3-month
- -2.5%
- RSI (14)
- 55
- vs SMA200
- +4.1%
- 52-wk position
- 68.5% -6.7% vs high
Quarterly trajectory
Revenue by quarter (oldest → newest)
| Quarter | Revenue | Op income | Net income | EBITDA |
|---|---|---|---|---|
| 2026-03-31 | $14.45B | $4.03B | $2.69B | $5.02B |
| 2025-12-31 | $17.56B | $3.69B | $-1.65B | $756.0M |
| 2025-09-30 | $16.65B | $3.55B | $3.54B | $5.65B |
| 2025-06-30 | $14.65B | $3.58B | $2.91B | $5.32B |
Recent news
- Bullish SINOPHARM (01099.HK) Establishes Strategic Partnership with Pfizer, Inc. (PFE.US) · 2026-06-15
- Neutral IMAAVY Breakthrough And Priority Review Reframe Johnson And Johnson Growth Story · 2026-06-14
- Somewhat-Bearish Pfizer Holds Near $26, Dividend Draws Watch as Drug Prices Cloud Outlook · 2026-06-14
- Neutral MYR Group, Inc. $MYRG Stake Trimmed by Next Century Growth Investors LLC · 2026-06-14
- Neutral Pfizer (PFE) Upgraded at RBC Capital. Here is Why · 2026-06-14
- Somewhat-Bearish Valneva's Restructuring Drive and Share Overhang Collide with High-Stakes Lyme Vaccine Filing · 2026-06-13
Sources this view read
- fundamentals Company overview & valuation (Alpha Vantage OVERVIEW)
- filing Quarterly financial statements (Alpha Vantage INCOME/BALANCE/CASH)
- earnings Reported earnings history (Alpha Vantage EARNINGS)
- prices Adjusted daily prices (Alpha Vantage TIME_SERIES_DAILY_ADJUSTED)